来自MSN

Recursion jumps as JP Morgan upgrades on lead program

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Asia One

I'm a 33-year-old millennial, but I'm not on TikTok and probably never will be

I'm a 33 year-old millennial and I'm not on TikTok. I don't post videos and I don't scroll endlessly at 2am while lying in bed, gaslighting myself that "I'll sleep in five minutes". I don't have ...